Back to results
US 2017/0320829 A1Published application
Compositions and methods of treating retinal disease
AssigneeAldeyra Therapeutics, Inc.
InventorsThomas A. Jordan, John E. Dowling, John Clifford Chabala
Life of this patent
Estimating the term…
Abstract
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
Claims7
1-35. (canceled)
A pharmaceutical composition comprising a compound selected from the group consisting of:
- and a pharmaceutically acceptable salt thereof;
- and a pharmaceutically acceptable carrier.
A method of treating macular degeneration, comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of:
- and a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.